Maternal and fetal serum transformed alpha-fetoprotein levels in normal pregnancy

Journal of Obstetrics and Gynaecology Research

Volumn 35, Issue 2, 2009, Pages 271-276

  González Bugatto, Fernando ^a,b   Foncubierta, Esther ^b   De Los Ángeles Bailén, María ^b   Illanes, Sebastián ^c   Hervías Vivancos, Blas ^b   Bartha, José L ^b  

^a University Hospital 'Puerta del Mar' ^*  (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Pregnancy; Transformed alpha fetoprotein; Umbilical cord

Indexed keywords

ALPHA FETOPROTEIN;

ARTICLE; BLOOD SAMPLING; CESAREAN SECTION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; LONGITUDINAL STUDY; MATERNAL SERUM; NORMAL HUMAN; PREGNANCY; PROSPECTIVE STUDY;

ADULT; ALPHA-FETOPROTEINS; FEMALE; FETAL BLOOD; HUMANS; PREGNANCY; PROTEIN STRUCTURE, TERTIARY;

EID: 63149089913     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2008.00931.x     Document Type: Article

References (32)

1. Brock DJ, Bolton AE, Monaghan JM. Prenatal diagnosis through maternal serum AFP measurement. Lancet 1973 2 : 293 294.
2. Wald NJ, Cuckle H, Brock JH, Peto R, Polani PE, Woodford FP. Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects. Lancet 1977 1 : 1323 1332.
3. Waller DK, Lustig LS, Cunningham GC, Feuchtbaum LB, Hook EB. The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications. Obstet Gynecol 1996 88 : 816 822.
4. Cusick W, Rodis JF, Vintzileos AM, Albini SM, McMahon M, Campbell WA. Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation. J Reprod Med 1996 41 : 327 332.
5. Akinbiyi AA. Unexplained elevated maternal serum alpha-fetoprotein in singleton pregnancies as a predictor of fetal risk. Int J Gynaecol Obstet 1996 53 : 17 21.
6. Huerta-Enochian G, Katz V, Erfurth S. The association of abnormal alpha-fetoprotein and adverse pregnancy outcome: Does increased fetal surveillance affect pregnancy outcome? Am J Obstet Gynecol 2001 184 : 1549 1555.
7. Chandra S, Scott H, Dodds L, Watts C, Blight C, Van Den Hof M. Unexplained elevated maternal serum alpha-fetoprotein and/or human chorionic gonadotropin and the risk of adverse outcomes. Am J Obstet Gynecol 2003 189 : 775 781.
8. Bartha JL, Comino-Delgado R, Arce F, Alba P, Broullon JR, Barahona M. Relationship between alpha-fetoprotein and fetal erythropoiesis. J Reprod Med 1999 44 : 689 697.
9. Bartha JL, Harrison G, Kyle PM, Soothill PW. Fetal serum alpha-fetoprotein in alloimmunised pregnancies. Prenat Diagn 2003 23 : 917 920.
10. Jerzak M, Bischof P. Apoptosis in the first trimester human placenta: The role in maintaining immune privilege at the maternal-foetal interface and in the trophoblast remodeling. Eur J Obstet Gynecol Reprod Biol 2002 100 : 138 142.
11. Liang OD, Korff T, Eckhardt J et al. Oncodevelopmental alpha-Fetoprotein acts as a selective proangiogenic factor on endothelial cell from the fetomaternal unit. J Clin Endocrinol Metab 2004 89 : 1415 1422.
12. Dudich E, Semenkova L, Gorbatova E et al. Growth-regulative activity of human alpha-fetoprotein for different types of tumor and normal cells. Tumour Biol 1998 19 : 30 40.
13. Mizejewski GJ. Levels of alpha-fetoprotein during pregnancy and early infancy in normal and disease states. Obstet Gynecol Surv 2003 58 : 804 826.
14. Mizejewski GJ. Biological roles of alpha-fetoprotein during pregnancy and perinatal development. Exp Biol Med 2004 229 : 439 463.
15. Mizejewski GJ, Vonnegut M, Jacobson HI. Estradiol-activated alpha-fetoprotein suppresses the uterotropic response to estrogens. Proc Natl Acad Sci USA 1983 80 : 2733 2737.
16. Mizejewski GJ. Alpha-fetoprotein structure and function: Relevance to isoforms, epitopes, and conformational variants. Exp Biol Med 2001 226 : 377 408.
17. Jacobson HI, Bennett JA, Mizejewski GJ. Inhibition of estrogen-dependent breast cancer growth by a reaction product of alpha-fetoprotein and estradiol. Cancer Res 1990 50 : 415 420.
18. Vakharia D, Mizejewski GJ. Human alpha-fetoprotein peptides bind estrogen receptor and estradiol, and suppress breast cancer. Breast Cancer Res Treat 2000 63 : 41 52.
19. Mizejewski GJ, Dias JA, Hauer CR, Henrikson KP, Gierthy J. Alpha-fetoprotein derived peptides: Assay of an estrogen-modifying regulatory segment. Mol Cell Endocrinol 1996 118 : 15 23.
20. Butterstein G, Morrison J, Mizejewski GJ. Effect of alpha-fetoprotein and derived peptides on insulin and estrogen induced fetotoxicity. Fetal Diagn Ther 2003 18 : 360 369.
21. Bartha JL, Illanes S, González-Bugatto F, Abdel-Fattah S, Mizejewski GJ, Soothill PW. Maternal serum transformed alpha-fetoprotein levels in women with intrauterine growth retardation. Fetal Diagn Ther 2007 22 : 294 298.
22. Mizejewski GJ, Keenan JF, Setty RP. Separation of the estrogen-activated growth-regulatory forms of alpha-fetoprotein in mouse amniotic fluid. Biol Reprod 1990 42 : 887 898.
23. Allen SH, Bennett JA, Mizejewski GJ, Andersen TT, Ferraris S, Jacobson HI. Purification of alpha-fetoprotein from human cord serum with demonstration of its antiestrogenic activity. Biochim Biophys Acta 1993 1202 : 135 142.
24. Uversky VN, Narizhneva NV, Ivanova TV, Kirkitadze MD, Tomashevski AY. Ligand-free form of human alpha-fetoprotein: Evidence for the molten globule state. FEBS Lett 1997 410 : 280 284.
25. Gillespie JR, Uversky VN. Structure and function of alpha-fetoprotein: A biophysical overview. Biochim Biophys Acta 2000 1480 : 41 56.
26. Benassayag C, Mignot TM, Haourigui M et al. High polyunsaturated fatty acid, thromboxane A2, and alpha-fetoprotein concentrations at the human feto-maternal interface. J Lipid Res 1997 38 : 276 286.
27. Naval J, Calvo M, Laborda J et al. Expression of mRNAs for alpha-fetoprotein (AFP) and albumin and incorporation of AFP and docosahexaenoic acid in baboon fetuses. J Biochem (Tokyo) 1992 111 : 649 654.
28. Vallette G, Vranckx R, Martin ME, Benassayag C, Nunez EA. Conformational changes in rodent and human alpha-fetoprotein: Influence of fatty acids. Biochim Biophys Acta 1989 997 : 302 312.
29. Mizejewski GJ, Butterstein G. Survey of functional activities of alpha-fetoprotein derived growth inhibitory peptides: Review and prospects. Curr Protein Pept Sci 2006 7 : 73 100.
30. Muehlemann M, Miller KD, Dauphinee M, Mizejewski GJ. Review of Growth Inhibitory Peptide as a biotherapeutic agent for tumor growth, adhesion, and metastasis. Cancer Metastasis Rev 2005 24 : 441 467.
31. Richardson BE, Hulka BS, Peck JL et al. Levels of maternal serum alpha-fetoprotein (AFP) in pregnant women and subsequent breast cancer risk. Am J Epidemiol 1998 148 : 719 727.
32. Melbye M, Wohlfahrt J, Lei U et al. Alpha-fetoprotein levels in maternal serum during pregnancy and maternal breast cancer incidence. J Natl Cancer Inst 2000 92 : 1001 1005.